Literature DB >> 5576334

The G-IX system. A cell surface allo-antigen associated with murine leukemia virus; implications regarding chromosomal integration of the viral genome.

E Stockert, L J Old, E A Boyse.   

Abstract

This report concerns a cell surface antigen (G(IX); G = Gross) which exhibits mendelian inheritance but which also appears de novo in cells that become productively infected with MuLV (Gross), the wild-type leukemia virus of the mouse. In normal mice, G(IX) is a cell surface allo-antigen confined to lymphoid cells and found in highest amount on thymocytes. Four categories of inbred mouse strains can be distinguished according to how much G(IX) antigen is expressed on their thymocytes. G(IX) (-) strains have none; in the three G(IX) (+) categories, G(IX) (3), G(IX) (2), and G(IX) (1), the amounts of G(IX) antigen present (per thymocyte) are approximately in the ratios 3:2:1. A study of segregating populations derived mainly from strain 129 (the prototype G(IX) (3) strain) and C57BL/6 (the prototype G(IX) (-) strain) revealed that two unlinked chromosomal genes are required for expression of G(IX) on normal lymphoid cells. The phenotype G(IX) (+) is expressed only when both genes are present, as in 129 mice. C57BL/6 carries neither of them. At one locus, expression of G(IX) is fully dominant over nonexpression (G(IX) fully expressed in heterozygotes). At the second locus, which is linked with H-2 (at a distance of 36.4 +/- 2.7 units) in group IX (locus symbol G(IX)), expression is semidominant (50% expression of G(IX) in heterozygotes); gene order T:H-2:Tla:G(IX). As a rule, when cells of G(IX) (-) mice or rats become overtly infected with MuLV (Gross), an event which occurs spontaneously in older mice of certain strains and which also commonly accompanies malignant transformation, their phenotype is converted to G(IX) (+). This invites comparison with the emergence of TL(+) leukemia cells in TL(-) mouse strains which has been observed in previous studies and which implies that TL(-) --> TL(+) conversion has accompanied leukemic transformation of such cells. So far the only example of G(IX) (-) --> G(IX) (+) conversion taking place without overt MuLV infection is represented by the occurrence of GCSA(-):G(IX) (+) myelomas in BALB/c (GCSA:G(IX) (-)) mice. Unlike the other Gross cell surface antigen described earlier, GCSA, which is invariably associated with MuLV (Gross) infection and never occurs in its absence, G(IX) antigen sometimes occurs independently of productive MuLV infection; for example, thymocytes and some leukemias of 129 mice are GCSA(-):G(IX) (+), and MuLV-producing sarcomas may be GCSA(+):G(IX) (-). The frequent emergence of cells of G(IX) (+) phenotype in all mouse strains implies that the structural gene coding for G(IX) antigen is common to all mice. There is precedent for this in the TL system, in which two of the Tla genes in linkage group IX appear to be ubiquitous among mice, but are normally expressed only in strains of mice carrying a second (expression) gene. It is not yet certain whether either of the two segregating genes belongs to the MuLV genome rather than to the cellular genome. This leaves the question whether MuLV may have a chromosomal integration site still debatable. But there is a good prospect that further genetic analysis will provide the answer and so elucidate the special relationship of leukemia viruses to the cells of their natural hosts.

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5576334      PMCID: PMC2138928          DOI: 10.1084/jem.133.6.1334

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  40 in total

1.  Ly-A and Ly-B: two systems of lymphocyte isoantigens in the mouse.

Authors:  E A Boyse; M Miyazawa; T Aoki; L J Old
Journal:  Proc R Soc Lond B Biol Sci       Date:  1968-06-11

2.  The murine leukemia-sarcoma virus complex.

Authors:  R J Huebner
Journal:  Proc Natl Acad Sci U S A       Date:  1967-09       Impact factor: 11.205

3.  Group-specific viral antigens in the milk and tissues of mice naturally infected with mammary tumor virus or Gross leukemia virus.

Authors:  R C Nowinski; L J Old; E A Boyse; E de Harven; G Geering
Journal:  Virology       Date:  1968-04       Impact factor: 3.616

4.  The G (Gross) leukemia antigen.

Authors:  L J Old; E A Boyse; E Stockert
Journal:  Cancer Res       Date:  1965-07       Impact factor: 12.701

Review 5.  On the natural history of the murine leukemias: presidential address.

Authors:  H S Kaplan
Journal:  Cancer Res       Date:  1967-08       Impact factor: 12.701

Review 6.  Antigens of tumors and leukemias induced by viruses.

Authors:  L J Old; E A Boyse
Journal:  Fed Proc       Date:  1965 Sep-Oct

7.  The inheritance of susceptibility to the Gross leukemia virus in mice.

Authors:  F Lilly
Journal:  Genetics       Date:  1966-03       Impact factor: 4.562

8.  A study of passive immunization against a transplanted G+ leukemia with specific antiserum.

Authors:  L J Old; E Stockert; E A Boyse; G Geering
Journal:  Proc Soc Exp Biol Med       Date:  1967-01

9.  Heritable histocompatibility changes: lysogeny in mice?

Authors:  D W Bailey
Journal:  Transplantation       Date:  1966-07       Impact factor: 4.939

10.  Antigens of leukemias induced by naturally occurring murine leukemia virus: their relation to the antigens of gross virus and other murine leukemia viruses.

Authors:  G Geering; L J Old; E A Boyse
Journal:  J Exp Med       Date:  1966-10-01       Impact factor: 14.307

View more
  108 in total

1.  Recombinant origins of leukemogenic murine viruses. Parke-Davis award lecture, 1978.

Authors:  R A Lerner
Journal:  Am J Pathol       Date:  1978-10       Impact factor: 4.307

2.  Cell surface antigens: invaluable landmarks reflecting the nature of cells.

Authors:  Toshitada Takahashi; Hiroshi Shiku
Journal:  Cancer Immun       Date:  2012-05-01

3.  T1 oligonucleotides that segregate with tropism and with properties of gp70 in recombinants between N- and B-tropic murine leukemia viruses.

Authors:  D V Faller; N Hopkins
Journal:  J Virol       Date:  1978-04       Impact factor: 5.103

4.  AKR-MuLV-associated cell surface antigens.

Authors:  J N Ihle; J D Longstreth; N H Pazmiño; W L McLellan; M G Hanna
Journal:  Med Microbiol Immunol       Date:  1977       Impact factor: 3.402

5.  Truncated gag products encoded by Gv-1-responsive endogenous retrovirus loci.

Authors:  P F Policastro; M Fredholm; M C Wilson
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

6.  Molecular cloning and characterization of gag-, pol-, and env-related gene sequences in the ev- chicken.

Authors:  C T Dunwiddie; R Resnick; M Boyce-Jacino; J N Alegre; A J Faras
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

7.  Abelson antigen: a viral tumor antigen that is also a differentiation antigen of BALB/c mice.

Authors:  R Risser; E Stockert; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

Review 8.  Host-gene control of C-type tumor virus-expression and tumorigenesis: relevance of studies in inbred mice to cancer in man and other species.

Authors:  H Meier; R J Huebner
Journal:  Proc Natl Acad Sci U S A       Date:  1971-11       Impact factor: 11.205

9.  Murine leukemia virus sequences are encoded in the murine major histocompatibility complex.

Authors:  D Meruelo; R Kornreich; A Rossomando; C Pampeno; A L Mellor; E H Weiss; R A Flavell; A Pellicer
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

10.  Nucleotide sequence of the env-specific segment of NFS-Th-1 xenotropic murine leukemia virus.

Authors:  R Repaske; R R O'Neill; A S Khan; M A Martin
Journal:  J Virol       Date:  1983-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.